-
Loading metrics
Cost-effectiveness of adjuvant paclitaxel and trastuzumab for early-stage node-negative, HER2-positive breast cancer
- Ali Hajjar,
- Mehmet A. Ergun,
- Oguzhan Alagoz,
- Murtuza Rampurwala
x
- Published: June 5, 2019
- https://doi.org/10.1371/journal.pone.0217778